Enspryng

News

Broken image of a woman through eyes in double-vision

FDA clears Roche's Enspryng for thyroid eye disease

Roche has claimed US approval for Enspryng in a second indication, thyroid eye disease, that makes it a rival to drugs from Amgen and Viridian.

News

Reviews underway of first drug for rare disease MOGAD

Patients with rare autoimmune disease MOGAD could be months away from having a first approved therapy, as the FDA starts a review of Roche's Enspryng.

News

New data build case for Roche's oral BTK drug for MS

Roche remains confident in the prospects for its soon-to-be-filed oral BTK drug fenebrutinib for multiple sclerosis, despite safety concerns.

News

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Roche's Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending the treatment options for people with the life-threatenin

FDA clears Roche's Enspryng for thyroid eye disease

Reviews underway of first drug for rare disease MOGAD

New data build case for Roche's oral BTK drug for MS

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

AI, start-ups, and the future of human health: AION Labs’ Ma...

Discover a new era of healthcare panel engagement: Grounded ...

Enspryng

Editor's Picks